120 related articles for article (PubMed ID: 147131)
1. Phase II trial of streptozotocin, mitomycin-C and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer.
Wiggans RG; Woolley PV; Macdonald JS; Smythe T; Ueno W; Schein PS
Cancer; 1978 Feb; 41(2):387-91. PubMed ID: 147131
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced adenocarcinoma of the pancreas with combinations of streptozotocin plus 5-fluorouracil and streptozotocin plus cyclophosphamide.
Moertel CG; Douglas HO; Hanley J; Carbone PP
Cancer; 1977 Aug; 40(2):605-8. PubMed ID: 142579
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.
Bukowski RM; Abderhalden RT; Hewlett JS; Weick JK; Groppe CW
Cancer Clin Trials; 1980; 3(4):321-4. PubMed ID: 6448716
[TBL] [Abstract][Full Text] [Related]
4. A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R
Cancer; 1991 Sep; 68(5):965-9. PubMed ID: 1833042
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
Oster MW; Gray R; Panasci L; Perry MC
Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
[TBL] [Abstract][Full Text] [Related]
6. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
[TBL] [Abstract][Full Text] [Related]
7. 5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas.
Smith FP; Hoth DF; Levin B; Karlin DA; MacDonald JS; Woolley PV; Schein PS
Cancer; 1980 Nov; 46(9):2014-8. PubMed ID: 7427908
[TBL] [Abstract][Full Text] [Related]
8. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
Moertel CG; Hanley JA; Johnson LA
N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group study.
Bukowski RM; Balcerzak SP; O'Bryan RM; Bonnet JD; Chen TT
Cancer; 1983 Nov; 52(9):1577-82. PubMed ID: 6225508
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of combination chemotherapy for pancreatic cancer with 5-fluorouracil, mitomycin C, and hexamethylmelamine.
Bruckner HW; Storch JA; Brown JC; Goldberg J; Chamberlin K
Oncology; 1983; 40(3):165-9. PubMed ID: 6405338
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinoma.
Bukowski RM; Schacter LP; Groppe CW; Hewlett JS; Weick JK; Livingston RB
Cancer; 1982 Jul; 50(2):197-200. PubMed ID: 6211223
[TBL] [Abstract][Full Text] [Related]
13. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
14. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
MacDonald JS; Woolley PV; Smythe T; Ueno W; Hoth D; Schein PS
Cancer; 1979 Jul; 44(1):42-7. PubMed ID: 455263
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin-C alone and in combination with infused 5-fluorouracil to the treatment of disseminated gastrointestinal carcinomas.
Buroker TR; Kim PN; Baker LH; Ratanatharathron V; Wojtaszak B; Vaitkevicius VK
Med Pediatr Oncol; 1978; 4(1):35-42. PubMed ID: 342890
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
Krauss S; Sonoda T; Solomon A
Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
[No Abstract] [Full Text] [Related]
17. Phase II trial of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin (MOF-Strep) in patients with disseminated pancreatic carcinoma.
Sordillo PP; Magill GB
Am J Clin Oncol; 1982 Jun; 5(3):277-9. PubMed ID: 6282110
[TBL] [Abstract][Full Text] [Related]
18. 5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage.
Biran H; Sulkes A; Biran S
Oncology; 1989; 46(2):83-7. PubMed ID: 2710481
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of ftorafur: adriamycin and mitomycin-C (FAM II) in advanced gastric adenocarcinoma.
Woolley PV; MacDonald JS; Smythe T; Haller DG; Hoth DF; Rosenoff S; Schein PS
Cancer; 1979 Oct; 44(4):1211-4. PubMed ID: 387203
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
De Jager RL; Magill GB; Golbey RB; Krakoff IH
Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
